SDC1 and Miyoshi myopathy: Targeting other immune checkpoint molecules such as LAG3, alone or in combination with XBP1/CD138/CS1 multi-peptide vaccination, holds promise for overcoming immunosuppression and enhancing anti-tumor immune responses in MM.